Department of Public Health Sciences
Garrett-Mayer joins Investigational Drug Steering Committee
| Dr. Elizabeth Garrett-Mayer to join the National Cancer Institute’s Investigational Drug Steering Committee (IDSC) as the Biostatistics Subject Matter Expert | |
 | Dr. Garrett-Mayer will join the National Cancer Institute’s Investigational Drug Steering Committee (IDSC) as the Biostatistics Subject Matter Expert. The IDSC was created at the recommendation of the National Cancer Institute’s Clinical Trials Working Group to assist with the design and prioritization of early phase drug development trials with agents for which the Cancer Therapy Evaluation Program (CTEP) holds an Investigational New Drug application (IND). |